Concepedia

Benjamin Carroll

BC

8

Publications

338

Citations

8

H-Index

2011

Active since

Affiliations

Teva Pharmaceuticals (United States)(Current)

Analysis Group (United States)

Optum (United States)

Benjamin Carroll is an author at Teva Pharmaceuticals (United States) specializing in medicine, pharmacology, and pain research.

ORCID

Top concepts

Publications per year

2011–2019

8

Publications

8

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease

Daniel O. Claassen, Benjamin Carroll, Lisa M. De Boer et al. · Journal of Clinical Movement Disorders · 2017 · 96 citations · Full text

Comparative therapeutic efficacy and safety of type‐II collagen (uc‐II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate

Ramesh C. Gupta, Terry D. Canerdy, Janette Lindley et al. · Journal of Animal Physiology and Animal Nutrition · 2011 · 77 citations

, , +17

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia

Joseph P. McEvoy, Sanjay Gandhi, Avery A. Rizio et al. · Quality of Life Research · 2019 · 54 citations · Full text

Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States

Anita M. Loughlin, Nancy D. Lin, Victor Abler et al. · PLoS ONE · 2019 · 29 citations · Full text

Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis

Oscar Patterson‐Lomba, Rajeev Ayyagari, Benjamin Carroll · BMC Neurology · 2019 · 25 citations · Full text

Rows per page

1–5 of 8